Study: Risk of Psoriasis Related to BMI
December 21, 2021

A study in the Journal of the American Academy of Dermatology examined the incidence of psoriasis according to body mass index.

Apremilast Use During COVID-19
December 21, 2021

A recent study investigated apremilast use for psoriasis during COVID-19 infection.

FDA Grants Priority Review to Spesolimab
December 15, 2021

The FDA grants Priority Review for spesolimab (BI655130; Boehringer Ingelheim) as a treatment for generalized pustular psoriasis.

Phase 3 Tapinarof Data Released
December 08, 2021

The New England Journal of Medicine has published the clinical trial data from the PSOARING 1 and PSOARING 2 studies on tapinarof treatment for plaque psoriasis.

JAK Inhibitors: Drilling Down the Details
November 25, 2021

In this exclusive video interview, James Q Del Rosso, DO, gets into the details of JAK inhibitors, explaining how they work and cutting through the headlines around the treatments.

Pairing the Right Psoriasis Drug with the Right Patient
November 13, 2021

In a video for Dermatology Times®, Mark Lebwohl, MD, details how to match patients with the right psoriasis treatment for their specific needs.

New Frontiers in Psoriatic Disease Research
November 11, 2021

An article published in the Journal of Investigative Dermatology examined genetic, environmental triggers, immunology, pathophysiology, and precision medicine in psoriasis.

Efficacy and Safety of Apremilast in Plaque Psoriasis
November 11, 2021

A phase 3 study evaluated apremilast as a treatment for patients with mild to moderate psoriasis.

A Deep Dive on Tapinarof
November 09, 2021

In this video interview, Mark Lebwohl, MD, explains why topicals for inflammatory conditions are vital for treatment.

The Cutaneous Connection: An Inside Look of the Inclusive Atlas
November 04, 2021

In this episode, we dive into the background of the “The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.” Adam Friedman, MD, and Misty Eleryan MD, MS, describe their process to creating this new dermatologic resource.